The new issue of the journal Current Drug Abuse Reviews is devoted to psychedelic research. The issue includes articles on the use of psychedelics for treating substance abuse, crisis intervention, and the subjective experiences of psilocybin users in an fMRI study.“We are witnessing a revival of...
Heffter-supported researchers at the University of Alabama and Johns Hopkins examined health data for 190,000 individuals and found that people who have used one of the classic psychedelic drugs are less prone to suicidal thoughts and actions.“Despite advances in mental health treatments, suicide rates generally...
An important new research study at the University of New Mexico confirms that psilocybin is a promising treatment for heavy drinkers. Heffter researcher Michael Bogenschutz and his colleagues studied 10 individuals who were alcohol dependent for an average of 15.1 years.“Abstinence did not increase significantly...
Light at the End of the Tunnel! Fall, 2014 Newsletter Dear Heffter Friends and Supporters: Why did I put that title at the top of this newsletter? Because after so many years of hard work, we now can actually see the final steps coming closer in our process...
An article in the New York Times Sunday Review section of November 29, 2014, discusses the use of psilocybin for treating depression and other serious medical conditions. Writer Eugenia Bone, the author of Mycophilia: Revelations From the Weird World of Mushrooms, covers the history and culture...
The Washington Post is featuring an article by Tom Shroder adapted from his book Acid Test: LSD, Ecstasy, and the Power to Heal (Blue Rider Press, 2014). Shroder covers the history of psychedelic research from Albert Hoffman’s discovery of LSD in the 1940s to recent...
In this presentation from the 2013 Psychedelic Science conference, Heffter researcher Stephen Ross discusses the use of psilocybin to treat addiction and psychological distress in cancer patients.Psilocybin, Addiction, and End of Life–Stephen Ross ...
Our video page features a new interview from the research study on psilocybin as a treatment for alcohol dependence conducted by Heffter researcher Michael Bogunschutz and his team at the University of New Mexico. Sarah, the volunteer subject interviewed in the video, is an alcoholic...
In this TEDxABQ talk, research scientist Robert Rhatigan discusses his recovery from alcoholism using the psychedelic ayahuasca. In addition to his personal story, Rhatigan gives a brief history of psychedelic research including the work of Heffter researcher Michael Bogenschutz, who studied the treatment of alcoholics...
For those of you who can speak German, here is a short clip from a film about Psilocybin as medicine featuring Heffter Board Member Dr. Franz Vollenweider.Sie wirken ähnlich wie die Droge LSD auf das Gehirn: Magic mushrooms verändern die Wahrnehmung, machen euphorisch und können...
